Consumer & Industrial review
Robust performance amid challenging market environment
In our Consumer & Industrial segment, we provide our customers with high-quality products and services specifically tailored to our customers’ needs. In the Industry business unit we design, develop and market a broad range of products such as dispensers, cartridges and mixers for two-component adhesives and sealants for use in construction, transportation, electronics, infrastructure and general industrial sectors. Micro-brushes and applicators for eyes, eyelashes, lips and facial make-up are the most important products of our Beauty business unit. They are sold to a broad customer base that ranges from regional to global brands and includes the most iconic names in the beauty industry.
Segment revenue and gross profit
|
millions of CHF |
|
2024 |
|
+/–% change |
|
+/–% organic 2) |
|
2023 |
|
|
Industry |
|
126.6 |
|
–3.3% |
|
–2.3% |
|
130.9 |
|
|
Beauty |
|
180.6 |
|
1.1% |
|
–3.2% |
|
178.6 |
|
|
Total revenue Consumer & Industrial (C&I) 1) |
|
307.2 |
|
–0.8% |
|
–2.8% |
|
309.6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment cost of goods sold |
|
–198.4 |
|
1.1% |
|
|
|
–200.5 |
|
|
Segment gross profit Consumer & Industrial (C&I) |
|
108.8 |
|
–0.2% |
|
|
|
109.0 |
|
1) Revenue from external customers.
2) Adjusted for acquisition and currency effects.
Revenue by business unit
2024
Revenue by business unit
2023
Industry – Solid performance in challenging markets
The Industry business unit delivered revenues of CHF 126.6 million in 2024, a decrease of 2.3% organically year-on-year, primarily driven by sluggish end markets and volume not recovered since our Poland exit. The Valencia facility – after a record build up phase of one year – is now delivering the full portfolio of industrial products. In 2025, medmix will focus on increasing efficiency and profitability through leaner product flows and automated production processes. Furthermore, the company is insourcing external manufacturing in the USA to the Atlanta site to enhance value creation.
medmix’ environmentally friendly greenLine product family reduces significantly the CO2 footprint of its customers by adopting up to 100% recycled plastics. Combined with our proven high quality standards, it provides customers with a competitive advantage – such as for SIKA, which recently decided to switch its current portfolio to our greenLine product range.
Our solutions provide customers with a competitive advantage. SIKA, for example, recently decided to switch its product portfolio to our greenLine product family, which significantly reduces the CO2 footprint.
Beauty growing profitably
Revenue in the Beauty business unit was CHF 180.6 million, a nominal increase of 1.1% compared to 2023. This was driven primarily by successful product launches and the strong contribution of the Qiaoyi acquisition, which is delivering on plan. The decline in organic revenue of 3.2% was mainly due to sluggish end markets worldwide and the corresponding lower order intake.
Across the GEKA portfolio, the company has delivered successful product launches with the customers throughout 2024 and increased profitability through new higher margin projects showcasing its broad capabilities.
Sustainable innovation
In 2024, medmix’ Beauty business unit introduced further improvements on its ShadowPrinting decoration technology which creates attractive and iconic surface structures without adding any material. Therefore, the recyclability remains unaffected by the decoration.
Definition of alternative performance measures (APMs):
For the definition of the alternative performance measures, please refer to the chapter alternative performance measures.